Related Experiment Video
Updated: Aug 22, 2025

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
Acute and postacute sequelae associated with SARS-CoV-2 reinfection
Benjamin Bowe1,2, Yan Xie1,2, Ziyad Al-Aly3,4,5,6,7
1Clinical Epidemiology Center, Research and Development Service, Veteran Affairs Saint Louis Health Care System, St. Louis, MO, USA.
COVID-19 reinfection significantly increases the risk of death, hospitalization, and long-term organ damage. These risks persist regardless of vaccination status, highlighting the need for reinfection prevention strategies.
Area of Science:
- Infectious Diseases
- Public Health
- Epidemiology
Background:
- First severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is linked to increased risks of death and organ system sequelae.
- The impact of SARS-CoV-2 reinfection on these risks remains unclear.
Purpose of the Study:
- To evaluate the additional risks of death, hospitalization, and incident sequelae associated with SARS-CoV-2 reinfection.
- To compare risks between individuals with no reinfection, reinfection, and no infection.
Main Methods:
- Utilized the US Department of Veterans Affairs national healthcare database.
- Constructed cohorts of individuals with one SARS-CoV-2 infection (n=443,588), reinfection (n=40,947), and no infection (n=5,334,729).
- Employed inverse probability-weighted survival models to estimate risks and 6-month burdens.
Main Results:
- Reinfection significantly increased risks of death (HR=2.17) and hospitalization (HR=3.32) compared to no reinfection.
- Additional risks included pulmonary, cardiovascular, diabetes, kidney, and neurological disorders, persisting for 6 months.
- Risks were evident regardless of vaccination status and increased with the number of infections.
Conclusions:
- SARS-CoV-2 reinfection poses substantial additional risks for adverse health outcomes, including death and multi-organ sequelae.
- These risks are present in both acute and post-acute phases and are independent of vaccination status.
- Strategies to prevent SARS-CoV-2 reinfection are crucial for reducing the overall burden of disease.
Related Concept Videos
Stages of Infection
Pneumonia II: Pathophysiology
Pneumonia III: Complications and Assessment
Endocarditis II: Clinical Features of Infective Endocarditis
Immunological Memory
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...

